Cargando…
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428982/ https://www.ncbi.nlm.nih.gov/pubmed/34509536 http://dx.doi.org/10.1016/j.jaad.2021.08.065 |
_version_ | 1783750476806750208 |
---|---|
author | Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Lu, Chenyue Theodosakis, Nicholas Klevens, R. Monina Estir, Hossein Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. |
author_facet | Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Lu, Chenyue Theodosakis, Nicholas Klevens, R. Monina Estir, Hossein Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. |
author_sort | Pahalyants, Vartan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8428982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | by the American Academy of Dermatology, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84289822021-09-10 Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Lu, Chenyue Theodosakis, Nicholas Klevens, R. Monina Estir, Hossein Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2022-01 2021-09-10 /pmc/articles/PMC8428982/ /pubmed/34509536 http://dx.doi.org/10.1016/j.jaad.2021.08.065 Text en © 2021 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Letter Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Lu, Chenyue Theodosakis, Nicholas Klevens, R. Monina Estir, Hossein Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts |
title | Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts |
title_full | Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts |
title_fullStr | Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts |
title_full_unstemmed | Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts |
title_short | Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts |
title_sort | immunosuppressive biologics did not increase the risk of covid-19 or subsequent mortality: a retrospective matched cohort study from massachusetts |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428982/ https://www.ncbi.nlm.nih.gov/pubmed/34509536 http://dx.doi.org/10.1016/j.jaad.2021.08.065 |
work_keys_str_mv | AT pahalyantsvartan immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT murphywilliams immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT klebanovnikolai immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT luchenyue immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT theodosakisnicholas immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT klevensrmonina immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT estirhossein immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT lillyevelyn immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT asgarimaryam immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts AT semenovyevgeniyr immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts |